Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 8 (2011), Issue 6 (June)

1. Antibodies reactive to non-HLA antigens in transplant glomerulopathy.
   J Am Soc Nephrol, 22(6): 1168-78. [Abstract] [Full-text]
2. Early loss of peritubular capillaries after kidney transplantation.
   J Am Soc Nephrol, 22(6): 1024-9. [Abstract] [Full-text]
3. Effect of kidney transplantation on outcomes among patients with hepatitis C.
   J Am Soc Nephrol, 22(6): 1152-60. [Abstract] [Full-text]
4. Ethical challenges in transplant practice in Latin America: the Aguascalientes Document.
   Nefrologia, 31(3): 275-85. [Abstract] [Full-text]
5. Reduced expression of arrestin beta 2 by graft monocytes during acute rejection of rat kidneys.
   Immunobiology, 216(7): 854-61. [Abstract] [Full-text]
6. Stability of dental implants in grafted bone in the anterior maxilla: longitudinal study.
   Br J Oral Maxillofac Surg, 49(4): 319-23. [Abstract] [Full-text]
7. Evaluation of the vessels of the lower leg before microsurgical fibular transfer. Part II: magnetic resonance angiography for standard preoperative assessment.
   Br J Oral Maxillofac Surg, 49(4): 275-80. [Abstract] [Full-text]
8. Evaluation of the vessels of the lower leg before microsurgical fibular transfer. Part I: anatomical variations in the arteries of the lower leg.
   Br J Oral Maxillofac Surg, 49(4): 270-4. [Abstract] [Full-text]
9. Association of operative time of day with outcomes after thoracic organ transplant.
   JAMA, 305(21): 2193-9. [Abstract] [Full-text]
10. The human metapneumovirus: a case series and review of the literature.
    Transpl Infect Dis, 13(3): 324-8. [Abstract] [Full-text]
11. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link?
    J Clin Invest, 121(6): 2155-7. [Abstract] [Full-text]
12. The effect of cancellous autograft and novel plate design on radiographic healing and postoperative complications in tibial tuberosity advancement for cranial cruciate-deficient canine stifles.
    Vet Surg, 40(4): 402-7. [Abstract] [Full-text]
13. Weissella confusa bacteremia in a liver transplant patient with hepatic artery thrombosis.
    Transpl Infect Dis, 13(3): 290-3. [Abstract] [Full-text]
14. Spinal surgery following organ transplantation.
    J Neurosurg Spine, 14(6): 779-84. [Abstract] [Full-text]
15. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis.
    Transpl Infect Dis, 13(3): 244-9. [Abstract] [Full-text]
16. Clinical significance of positive cranial bone flap cultures and associated risk of surgical site infection after craniotomies or craniectomies.
    J Neurosurg, 114(6): 1746-54. [Abstract] [Full-text]
17. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature.
    Transpl Infect Dis, 13(3): 312-7. [Abstract] [Full-text]
18. Management of voriconazole hepatotoxicity in a lung transplant patient.
    Transpl Infect Dis, 13(3): 309-11. [Abstract] [Full-text]
19. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient.
    Transpl Infect Dis, 13(3): 303-8. [Abstract] [Full-text]
20. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Transpl Infect Dis, 13(3): 299-302. [Abstract] [Full-text]
21. Incidence and impact of herpes simplex and cytomegalovirus detection in the respiratory tract after lung transplantation.
    Transpl Infect Dis, 13(3): 259-65. [Abstract] [Full-text]
22. Successful kidney transplantation after coccidioidal meningitis.
    Transpl Infect Dis, 13(3): 285-9. [Abstract] [Full-text]
23. Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient.
    Transpl Infect Dis, 13(3): 278-84. [Abstract] [Full-text]
24. Polymorphism in 3'-untranslated region of toll-like receptor 4 gene is associated with protection from hepatitis B virus recurrence after liver transplantation.
    Transpl Infect Dis, 13(3): 250-8. [Abstract] [Full-text]
25. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
    Transpl Infect Dis, 13(3): 318-23. [Abstract] [Full-text]
26. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
    Clin Nucl Med, 36(7): 587-9. [Abstract] [Full-text]
27. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience.
    J Cardiovasc Med (Hagerstown), 12(7): 460-8. [Abstract] [Full-text]
28. Treatment of intrabony periodontal defects with platelet-rich plasma versus platelet-poor plasma combined with a bovine-derived xenograft: a controlled clinical trial.
    J Periodontol, 82(6): 837-44. [Abstract] [Full-text]
29. Bone microbial decontamination agents in osseous grafting: an in vitro study with fresh human explants.
    J Periodontol, 82(6): 863-71. [Abstract] [Full-text]
30. Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts.
    Am J Pathol, 178(6): 2461-9. [Abstract] [Full-text]
31. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
    Nephrol Dial Transplant, 26(6): 2032-6. [Abstract] [Full-text]
32. Systematic review of anterior interbody fusion techniques for single- and double-level cervical degenerative disc disease.
    Spine (Phila Pa 1976), 36(14): E950-60. [Abstract] [Full-text]
33. Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B.
    Nephrol Dial Transplant, 26(6): 2037-41. [Abstract] [Full-text]
34. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression.
    Nephrol Dial Transplant, 26(6): 1769-75. [Abstract] [Full-text]
35. Severe symptomatic hyponatremia--an uncommon presentation of tacrolimus nephrotoxicity.
    Nephrol Dial Transplant, 26(6): 2042-4. [Abstract] [Full-text]
36. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.
    Gastroenterology, 140(7): 1980-9. [Abstract] [Full-text]
37. Association between the malnutrition-inflammation score and post-transplant anaemia.
    Nephrol Dial Transplant, 26(6): 2000-6. [Abstract] [Full-text]
38. Does a plain X-ray of the pelvis predict arterial complications in renal transplantation? A prospective study.
    Nephrol Dial Transplant, 26(6): 2007-12. [Abstract] [Full-text]
39. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.
    Nephrol Dial Transplant, 26(6): 2013-7. [Abstract] [Full-text]
40. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model.
    Nephrol Dial Transplant, 26(6): 1813-20. [Abstract] [Full-text]
41. An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients.
    Nephrol Dial Transplant, 26(6): 2018-24. [Abstract] [Full-text]
42. The feasibility of transoesophageal bioimpedance measurements for the detection of heart graft rejection.
    Physiol Meas, 32(7): 867-76. [Abstract] [Full-text]
43. The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft case.
    Am J Transplant, 11(6): 1325-9. [Abstract] [Full-text]
44. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival.
    Am J Transplant, 11(6): 1287-95. [Abstract] [Full-text]
45. Disclosing recipient information to potential living donors: preferences of donors and recipients, before and after surgery.
    Am J Transplant, 11(6): 1270-8. [Abstract] [Full-text]
46. IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection.
    Am J Transplant, 11(6): 1248-59. [Abstract] [Full-text]
47. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation.
    Am J Transplant, 11(6): 1236-47. [Abstract] [Full-text]
48. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.
    Am J Transplant, 11(6): 1218-25. [Abstract] [Full-text]
49. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
    Am J Transplant, 11(6): 1140-7. [Abstract] [Full-text]
50. Antibody-mediated rejection--an ounce of prevention is worth a pound of cure.
    Am J Transplant, 11(6): 1131-9. [Abstract] [Full-text]
51. Has transplantation lost its luster?
    Am J Transplant, 11(6): 1109-10. [Abstract] [Full-text]
52. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
    Liver Int, 31(6): 792-801. [Abstract] [Full-text]
53. Living donor age and kidney transplant outcomes.
    Am J Transplant, 11(6): 1279-86. [Abstract] [Full-text]
54. Post-transplant lymphoproliferative disorders: determination of donor/recipient origin in a large cohort of kidney recipients.
    Am J Transplant, 11(6): 1260-9. [Abstract] [Full-text]
55. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.
    Am J Transplant, 11(6): 1226-35. [Abstract] [Full-text]
56. Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection.
    J Immunol, 186(12): 6830-8. [Abstract] [Full-text]
57. Reduction of cold ischemia-reperfusion injury by graft-expressing clusterin in heart transplantation.
    J Heart Lung Transplant, 30(7): 819-26. [Abstract] [Full-text]
58. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.
    J Heart Lung Transplant, 30(7): 841-3. [Abstract] [Full-text]
59. Cytomegalovirus prostatitis in a heart transplant recipient.
    Am J Transplant, 11(6): 1330-3. [Abstract] [Full-text]
60. Quality of life in kidney donors.
    Am J Transplant, 11(6): 1315-9. [Abstract] [Full-text]
61. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation.
    Am J Transplant, 11(6): 1302-7. [Abstract] [Full-text]
62. Laparoscopic kidney transplantation: an initial experience.
    Am J Transplant, 11(6): 1320-4. [Abstract] [Full-text]
63. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
    J Heart Lung Transplant, 30(7): 778-82. [Abstract] [Full-text]
64. Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality.
    J Heart Lung Transplant, 30(7): 790-8. [Abstract] [Full-text]
65. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction.
    J Heart Lung Transplant, 30(7): 783-9. [Abstract] [Full-text]
66. Usefulness of qualitative polymerase chain reaction for Trypanosoma cruzi DNA in endomyocardial biopsy specimens of chagasic heart transplant patients.
    J Heart Lung Transplant, 30(7): 799-804. [Abstract] [Full-text]
67. Prevention of transplant coronary artery disease by prenylation inhibitors.
    J Heart Lung Transplant, 30(7): 761-9. [Abstract] [Full-text]
68. Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery.
    Am J Transplant, 11(6): 1308-14. [Abstract] [Full-text]
69. Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study.
    J Heart Lung Transplant, 30(7): 770-7. [Abstract] [Full-text]
70. An update on donor-derived disease transmission in organ transplantation.
    Am J Transplant, 11(6): 1123-30. [Abstract] [Full-text]
71. Five-year outcomes with alemtuzumab induction after lung transplantation.
    J Heart Lung Transplant, 30(7): 743-54. [Abstract] [Full-text]
72. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    J Heart Lung Transplant, 30(7): 735-42. [Abstract] [Full-text]
73. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy.
    J Heart Lung Transplant, 30(7): 755-60. [Abstract] [Full-text]
74. Renal transplantation in a boy with methylmalonic acidaemia.
    J Inherit Metab Dis, 34(3): 695-700. [Abstract] [Full-text]
75. Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.
    Am J Transplant, 11(6): 1188-200. [Abstract] [Full-text]
76. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates.
    Sci Transl Med, 3(86): 86ra51. [Abstract] [Full-text]
77. Transplantation tolerance: memories that haunt us.
    Sci Transl Med, 3(86): 86ps22. [Abstract] [Full-text]
78. Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients.
    Clin Transplant, 25(3): E356-65. [Abstract] [Full-text]
79. Venous outflow obstruction after orthotopic liver transplantation: use of a breast implant to maintain graft position.
    Clin Transplant, 25(3): E320-6. [Abstract] [Full-text]
80. Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.
    Clin J Am Soc Nephrol, 6(6): 1488-94. [Abstract] [Full-text]
81. Living donor exchange programs: theory and practice.
    Br Med Bull, 98: 21-30. [Abstract] [Full-text]
82. Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States.
    Clin J Am Soc Nephrol, 6(6): 1481-7. [Abstract] [Full-text]
83. Assessment of variation in live donor kidney transplantation across transplant centers in the United States.
    Transplantation, 91(12): 1357-63. [Abstract] [Full-text]
84. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Eur J Gastroenterol Hepatol, 23(7): 559-65. [Abstract] [Full-text]
85. Long-term effects of kidney donation on renal function and blood pressure in African Americans.
    Clin J Am Soc Nephrol, 6(6): 1474-80. [Abstract] [Full-text]
86. Graft failure and adaptation period to adult healthcare centers in pediatric renal transplant patients.
    Transplantation, 91(12): 1380-5. [Abstract] [Full-text]
87. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.
    Clin Transplant, 25(3): 345-51. [Abstract] [Full-text]
88. Patient participation in research among solid organ transplant recipients in the United States.
    Transplantation, 91(12): 1424-35. [Abstract] [Full-text]
89. Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation.
    Transplantation, 91(12): 1392-7. [Abstract] [Full-text]
90. Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis.
    Transplantation, 91(12): 1406-11. [Abstract] [Full-text]
91. Native nephrectomy for renal cell carcinoma in transplant recipients.
    Transplantation, 91(12): 1376-9. [Abstract] [Full-text]
92. Stromal activation and formation of lymphoid-like stroma in chronic lung allograft dysfunction.
    Transplantation, 91(12): 1398-405. [Abstract] [Full-text]
93. Simultaneous liver and kidney transplants: optimizing use of this double resource.
    Transplantation, 91(12): 1305-9. [Abstract] [Full-text]
94. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience.
    Transplantation, 91(12): 1370-5. [Abstract] [Full-text]
95. Regenerative medicine and organ transplantation: past, present, and future.
    Transplantation, 91(12): 1310-7. [Abstract] [Full-text]
96. Posttransplant sCD30 as a predictor of kidney graft outcome.
    Transplantation, 91(12): 1364-9. [Abstract] [Full-text]
97. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation.
    Clin Transplant, 25(3): E292-6. [Abstract] [Full-text]
98. Rare malposition of a central venous catheter into the left internal mammary vein in a liver transplantation patient.
    J Anesth, 25(3): 462-4. [Abstract] [Full-text]
99. Improving graft survival for patients undergoing liver transplantation.
    Clin Transplant, 25(3): E345-55. [Abstract] [Full-text]
100. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients.
     Clin J Am Soc Nephrol, 6(6): 1463-73. [Abstract] [Full-text]
101. Graft volume as the surrogate marker for nephron number affects the outcomes of living-donor kidney transplantation.
     Clin Transplant, 25(3): E327-35. [Abstract] [Full-text]
102. Irreversible immunoexpression of matrix metalloproteinase-9 in proximal tubular epithelium of renal allografts with acute rejection.
     Clin Transplant, 25(3): E336-44. [Abstract] [Full-text]
103. Two cases of massive pleural effusion noted only after induction of anesthesia in living donor liver transplantation.
     J Anesth, 25(3): 418-21. [Abstract] [Full-text]
104. Growth of a nation part I: impact of organ donor obesity on whole-organ pancreas transplantation.
     Clin Transplant, 25(3): E225-32. [Abstract] [Full-text]
105. Attitudes toward live donor kidney transplantation and its commercialization.
     Clin Transplant, 25(3): E312-9. [Abstract] [Full-text]
106. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
     Clin Transplant, 25(3): E297-303. [Abstract] [Full-text]
107. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
     Clin Transplant, 25(3): E284-91. [Abstract] [Full-text]
108. Long-term kidney transplant outcome in obese patients in a predominantly African American population.
     Clin Transplant, 25(3): E264-70. [Abstract] [Full-text]
109. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
     Clin Transplant, 25(3): E243-9. [Abstract] [Full-text]
110. Extended criteria donors in liver transplant candidates with hepatorenal syndrome.
     Clin Transplant, 25(3): E257-63. [Abstract] [Full-text]
111. Donor risk score and baseline biopsy CADI value predict kidney graft outcome.
     Clin Transplant, 25(3): E276-83. [Abstract] [Full-text]
112. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
     Clin Transplant, 25(3): E250-6. [Abstract] [Full-text]
113. Management of peripheral vascular disease compromising renal allograft placement and function: review of the literature with an illustrative case.
     Clin Transplant, 25(3): 337-44. [Abstract] [Full-text]
114. Does trochanteric transfer eliminate the Trendelenburg sign in adults?
     Clin Orthop Relat Res, 469(7): 1984-90. [Abstract] [Full-text]
115. Surgical management of biliary complications following living donor liver transplantation.
     Clin Transplant, 25(3): 504-10. [Abstract] [Full-text]
116. Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation.
     Chest, 139(6): 1451-7. [Abstract] [Full-text]
117. Kidney transplantation in the morbidly obese: complicated but still better than dialysis.
     Clin Transplant, 25(3): 401-5. [Abstract] [Full-text]
118. Muco-cutaneous manifestations in 178 renal transplant recipients.
     Clin Transplant, 25(3): 395-400. [Abstract] [Full-text]
119. The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation.
     Clin Transplant, 25(3): 450-6. [Abstract] [Full-text]
120. Pre-operative dietary restriction is feasible in live-kidney donors.
     Clin Transplant, 25(3): 486-94. [Abstract] [Full-text]
121. Medical epidemiology of patients surviving ten years after liver transplantation.
     Clin Transplant, 25(3): 360-7. [Abstract] [Full-text]
122. Retroperitoneoscopic living donor nephrectomy: initial experience with a unique hand-assisted approach.
     Clin Transplant, 25(3): 352-9. [Abstract] [Full-text]
123. Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation.
     Clin Transplant, 25(3): 406-16. [Abstract] [Full-text]
124. Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients.
     Clin Transplant, 25(3): 368-74. [Abstract] [Full-text]
125. Attitude toward xenotransplantation of patients prior and after human organ transplantation.
     Clin Transplant, 25(3): 495-503. [Abstract] [Full-text]
126. Steroid minimization for sirolimus-treated renal transplant recipients.
     Clin Transplant, 25(3): 457-67. [Abstract] [Full-text]
127. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era.
     Clin Transplant, 25(3): 420-5. [Abstract] [Full-text]
128. Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.
     Clin Transplant, 25(3): 436-43. [Abstract] [Full-text]
129. A comparison of registered and unregistered organ donors' perceptions about transplant recipients.
     Clin Transplant, 25(3): 444-9. [Abstract] [Full-text]
130. Osteoporosis in lung transplant candidates compared to matched healthy controls.
     Clin Transplant, 25(3): 426-35. [Abstract] [Full-text]
131. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?
     Clin Transplant, 25(3): 417-9. [Abstract] [Full-text]
132. Long-term outcome of pediatric renal transplantation: a single center experience.
     Clin Transplant, 25(3): 388-94. [Abstract] [Full-text]
133. Outcomes of renal transplantation in recipients with Wegener's granulomatosis.
     Clin Transplant, 25(3): 380-7. [Abstract] [Full-text]
134. Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.
     Clin Transplant, 25(3): 375-9. [Abstract] [Full-text]
135. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs.
     Transplantation, 91(12): 1347-56. [Abstract] [Full-text]
136. Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study.
     Transplantation, 91(12): 1326-32. [Abstract] [Full-text]
137. New-onset diabetes and nephropathy after renal transplantation.
     Contrib Nephrol, 170: 247-55. [Abstract] [Full-text]
138. Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy.
     Contrib Nephrol, 170: 237-46. [Abstract] [Full-text]
139. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
     J Surg Res, 169(1): e69-75. [Abstract] [Full-text]
140. Ingraft chimerism in lung transplantation--a study in a porcine model of obliterative bronchiolitis.
     Respir Res, 12: 56. [Abstract] [Full-text]
141. Prolonged time between donor brain death and organ retrieval results in an increased risk of mortality in cardiac transplant recipients.
     Interact Cardiovasc Thorac Surg, 12(6): 938-42. [Abstract] [Full-text]
142. Psychological characterization of demoralization in the setting of heart transplantation.
     J Clin Psychiatry, 72(5): 648-54. [Abstract] [Full-text]
143. Perioperative management of partial face transplantation involving a heparin antibody-positive donor.
     J Clin Anesth, 23(4): 318-21. [Abstract] [Full-text]
144. Tibial plateau fracture after primary anatomic double-bundle anterior cruciate ligament reconstruction: a case report.
     Arthroscopy, 27(5): 735-40. [Abstract] [Full-text]
145. A biomechanical comparison of 2 femoral fixation techniques for anterior cruciate ligament reconstruction in skeletally immature patients: over-the-top fixation versus transphyseal technique.
     Arthroscopy, 27(5): 672-80. [Abstract] [Full-text]
146. Anterior cruciate ligament reconstruction using patellar tendon versus hamstring tendon: a prospective comparative study with 9-year follow-up.
     Arthroscopy, 27(5): 653-65. [Abstract] [Full-text]
147. Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.
     J Urol, 186(1): 219-23. [Abstract] [Full-text]
148. Comparison of Real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan.
     Virol J, 8: 222. [Abstract] [Full-text]
149. MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation.
     Orphanet J Rare Dis, 6: 19. [Abstract] [Full-text]
150. Persistent hypocalcemia associated with therapeutic plasma exchange performed to reduce HLA antibody levels in cardiac transplant recipients.
     Transfus Apher Sci, 44(3): 243-8. [Abstract] [Full-text]
151. Long-term degradation of a poly-lactide co-glycolide/β-tricalcium phosphate biocomposite interference screw.
     Arthroscopy, 27(5): 637-43. [Abstract] [Full-text]
152. Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
     Seizure, 20(6): 500-1. [Abstract] [Full-text]
153. Utilization of surgical trepan for the obtainment of calvarial autogenous bone graft in maxillary reconstructions.
     J Oral Implantol, 37(3): 347-51. [Abstract] [Full-text]
154. Sandwich bone graft covered with buccal fat pad in severely atrophied edentulous maxilla: a clinical report.
     J Oral Implantol, 37(3): 361-6. [Abstract] [Full-text]
155. Rapid estimation of split renal function in kidney donors using software developed for computed tomographic renal volumetry.
     Eur J Radiol, 79(1): 15-20. [Abstract] [Full-text]
156. A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation.
     Ann Surg, 254(1): 145-54. [Abstract] [Full-text]
157. Malignancies after kidney transplantation: a 40-year single-center experience in Korea.
     Transpl Int, 24(7): 716-21. [Abstract] [Full-text]
158. Differential effects of cyclosporine and tacrolimus on arterial function.
     Transpl Int, 24(7): 708-15. [Abstract] [Full-text]
159. Prognostic value of intraoperative renal tissue oxygenation measurement on early renal transplant function.
     Transpl Int, 24(7): 687-96. [Abstract] [Full-text]
160. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.
     Transpl Int, 24(7): 666-75. [Abstract] [Full-text]
161. Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.
     Transpl Int, 24(7): 657-65. [Abstract] [Full-text]
162. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
     Transpl Int, 24(7): 640-50. [Abstract] [Full-text]
163. Surgical wound complications after heart transplantation.
     Transpl Int, 24(7): 627-36. [Abstract] [Full-text]
164. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
     Transpl Int, 24(7): 651-6. [Abstract] [Full-text]
165. Surface modification by glow discharge gasplasma treatment improves vascularization of allogenic bone implants.
     J Orthop Res, 29(8): 1237-44. [Abstract] [Full-text]
166. The effects of multiple freeze-thaw cycles on the biomechanical properties of the human bone-patellar tendon-bone allograft.
     J Orthop Res, 29(8): 1193-8. [Abstract] [Full-text]
167. Impact of pre-transplant liver hemodynamics and portal reconstruction techniques on post-transplant portal vein complications in pediatric liver transplantation: a retrospective analysis in 197 recipients.
     Ann Surg, 254(1): 55-61. [Abstract] [Full-text]
168. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation.
     Eur J Clin Pharmacol, 67(7): 671-9. [Abstract] [Full-text]
169. The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine.
     Value Health, 14(4): 443-9. [Abstract] [Full-text]
170. Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD).
     Pediatr Blood Cancer, 57(2): 324-8. [Abstract] [Full-text]
171. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT).
     J Vis Exp. [Abstract] [Full-text]
172. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.
     Ann Surg Oncol, 18(7): 1964-71. [Abstract] [Full-text]
173. Routine drainage for orthotopic liver transplantation.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
174. Secondary bone grafting for alveolar cleft in children with cleft lip or cleft lip and palate.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
175. Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation.
     World J Gastroenterol, 17(21): 2626-31. [Abstract] [Full-text]
176. Does the United States do it better? A comparative analysis of liver allocation protocols in the United Kingdom and the United States.
     Camb Q Healthc Ethics, 20(3): 418-33. [Abstract] [Full-text]
177. A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.
     J Med Virol, 83(8): 1395-400. [Abstract] [Full-text]
178. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
     Antimicrob Agents Chemother, 55(7): 3564-6. [Abstract] [Full-text]
179. Both patient and caregiver gender impact depressive symptoms among organ transplant caregivers: who is at risk and why?
     J Health Psychol, 16(5): 843-56. [Abstract] [Full-text]
180. Fracture incidence after liver transplantation: results of a 10-year audit.
     QJM, 104(7): 599-606. [Abstract] [Full-text]
181. Human cytomegalovirus and kidney transplantation: a clinician's update.
     Am J Kidney Dis, 58(1): 118-26. [Abstract] [Full-text]
182. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation.
     J Thorac Cardiovasc Surg, 142(1): 47-52.e3. [Abstract] [Full-text]
183. Identification of urologic complications after kidney transplant.
     Am J Kidney Dis, 58(1): 150-3. [Abstract] [Full-text]
184. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
     Am J Kidney Dis, 58(1): 109-12. [Abstract] [Full-text]
185. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients.
     Am J Kidney Dis, 58(1): 101-8. [Abstract] [Full-text]
186. Intragraft vascular occlusive sickle crisis with early renal allograft loss in occult sickle cell trait.
     Hum Pathol, 42(7): 1027-33. [Abstract] [Full-text]
187. Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function.
     Arch Surg, 146(6): 704-10. [Abstract] [Full-text]
188. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
     Arch Surg, 146(6): 683-9. [Abstract] [Full-text]
189. Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors.
     Transplantation, 92(1): 70-5. [Abstract] [Full-text]
190. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection.
     Transplantation, 92(1): 41-7. [Abstract] [Full-text]
191. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy.
     Transplantation, 92(1): 48-53. [Abstract] [Full-text]
192. Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation.
     Transplantation, 92(1): 82-7. [Abstract] [Full-text]
193. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea.
     Transplantation, 92(1): 61-9. [Abstract] [Full-text]
194. Single-center experience with kidney transplantation using deceased donors older than 75 years.
     Transplantation, 92(1): 76-81. [Abstract] [Full-text]
195. Cyclosporine A-based immunotherapy in adult living donor liver transplantation: accurate and improved therapeutic drug monitoring by 4-hr intravenous infusion.
     Transplantation, 92(1): 100-5. [Abstract] [Full-text]
196. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood.
     Transplantation, 92(1): 54-60. [Abstract] [Full-text]
197. Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database.
     Transplantation, 92(1): 31-5. [Abstract] [Full-text]
198. Magnetic resonance cholangiography in living donor liver transplantation.
     Transplantation, 92(1): 94-9. [Abstract] [Full-text]
199. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.
     Transplantation, 92(1): 36-40. [Abstract] [Full-text]
200. Luminex-based desensitization protocols: the University of Wisconsin initial experience.
     Transplantation, 92(1): 12-7. [Abstract] [Full-text]
201. Efficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection.
     Arch Dermatol, 147(6): 689-95. [Abstract] [Full-text]
202. Densitometric threshold and vertebral fractures in heart transplant patients.
     Transplantation, 92(1): 106-11. [Abstract] [Full-text]
203. Successful long-term use of sitagliptin for the treatment of new-onset diabetes mellitus after solid organ transplantation: a case report.
     Transplant Proc, 43(5): 2113-5. [Abstract] [Full-text]
204. Extracorporeal shockwave lithotripsy of ureteral stone in a patient with en bloc kidney transplantation: a case report.
     Transplant Proc, 43(5): 2110-2. [Abstract] [Full-text]
205. Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year.
     Transplant Proc, 43(5): 2107-9. [Abstract] [Full-text]
206. A case report: hepatic posttransplant lymphoproliferative disorder in a non-liver transplant patient.
     Transplant Proc, 43(5): 2102-6. [Abstract] [Full-text]
207. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
     Transplant Proc, 43(5): 2097-101. [Abstract] [Full-text]
208. Supradiaphragmatic approach for Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt stent in combination with inferior vena cava reconstruction during living donor liver transplantation: a case report.
     Transplant Proc, 43(5): 2093-6. [Abstract] [Full-text]
209. Neo-suprahepatic cava: a case report of a modified technique for domino liver transplantation.
     Transplant Proc, 43(5): 2090-2. [Abstract] [Full-text]
210. End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report.
     Transplant Proc, 43(5): 2087-9. [Abstract] [Full-text]
211. Hepatic artery thrombosis after liver transplantation: three case reports.
     Transplant Proc, 43(5): 2082-6. [Abstract] [Full-text]
212. Neutrophilic reversible airways dysfunction after liver transplantation: a case report.
     Transplant Proc, 43(5): 2078-81. [Abstract] [Full-text]
213. The use of terlipressin for management of dynamic left ventricular outflow tract obstruction complicating orthotropic liver transplantation: a case report.
     Transplant Proc, 43(5): 2075-7. [Abstract] [Full-text]
214. Liver transplantation is possible in some patients with liver metastasis of colon cancer.
     Transplant Proc, 43(5): 2070-4. [Abstract] [Full-text]
215. Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report.
     Transplant Proc, 43(5): 2066-9. [Abstract] [Full-text]
216. Successful lung retransplantation after extended use of extracorporeal membrane oxygenation as a bridge.
     Transplant Proc, 43(5): 2063-5. [Abstract] [Full-text]
217. Minimally invasive resection of a right atrial mass in a cardiac transplant recipient: a case report.
     Transplant Proc, 43(5): 2059-62. [Abstract] [Full-text]
218. Mycotic pseudoaneurysm of the ascending aorta after heart transplantation: case report.
     Transplant Proc, 43(5): 2055-8. [Abstract] [Full-text]
219. Immunoregulation effect by overexpression of heme oxygenase-1 on cardiac xenotransplantation.
     Transplant Proc, 43(5): 1994-7. [Abstract] [Full-text]
220. Effect of CD4+ memory T cells on rejection response of ectopic heart transplantation in mice.
     Transplant Proc, 43(5): 1989-93. [Abstract] [Full-text]
221. Heme oxygenase-1 expression and its significance for acute rejection following kidney transplantation in rats.
     Transplant Proc, 43(5): 1980-4. [Abstract] [Full-text]
222. Antibody-mediated response in rat liver chronic rejection.
     Transplant Proc, 43(5): 1976-9. [Abstract] [Full-text]
223. Expression of glucocorticoid-induced tumor necrosis factor receptor ligand in rat graft after liver transplantation.
     Transplant Proc, 43(5): 1971-5. [Abstract] [Full-text]
224. Interleukin-23 promotes natural killer T-cell production of IL-17 during rat liver transplantation.
     Transplant Proc, 43(5): 1962-6. [Abstract] [Full-text]
225. Porcine partial liver transplantation without veno-venous bypass: an effective model for small-for-size liver graft injury.
     Transplant Proc, 43(5): 1953-61. [Abstract] [Full-text]
226. Early posttransplantation hemoglobin level corresponds with chronic renal dysfunction in heart transplant recipients.
     Transplant Proc, 43(5): 1939-43. [Abstract] [Full-text]
227. Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures.
     Transplant Proc, 43(5): 1908-12. [Abstract] [Full-text]
228. Rapid decline in glomerular filtration rate during the first weeks following heart transplantation.
     Transplant Proc, 43(5): 1904-7. [Abstract] [Full-text]
229. Soluble tumor necrosis factor-like weak inducer of apoptosis plasma levels as a novel biomarker of endothelial function in prevalent orthotopic heart transplant recipients.
     Transplant Proc, 43(5): 1900-3. [Abstract] [Full-text]
230. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.
     Transplant Proc, 43(5): 1893-9. [Abstract] [Full-text]
231. Prophylaxis of cytomegalovirus disease in mismatched patients after heart transplantation using combined antiviral and immunoglobulin therapy.
     Transplant Proc, 43(5): 1887-92. [Abstract] [Full-text]
232. Effect of pulmonary hypertension in patients with end-stage lung disease on posttransplantation outcomes.
     Transplant Proc, 43(5): 1881-6. [Abstract] [Full-text]
233. Tumor necrosis factor-related apoptosis-inducing ligand is a marker of kidney function and inflammation in heart and kidney transplant recipients.
     Transplant Proc, 43(5): 1877-80. [Abstract] [Full-text]
234. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy.
     Transplant Proc, 43(5): 1871-6. [Abstract] [Full-text]
235. Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation.
     Transplant Proc, 43(5): 1868-70. [Abstract] [Full-text]
236. Increased incidence of acute graft rejection on calcineurin inhibitor-free immunosuppression after heart transplantation.
     Transplant Proc, 43(5): 1862-7. [Abstract] [Full-text]
237. Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis.
     Transplant Proc, 43(5): 1853-61. [Abstract] [Full-text]
238. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.
     Transplant Proc, 43(5): 1847-52. [Abstract] [Full-text]
239. Everolimus plus dosage reduction of cyclosporine in cardiac transplant recipients with chronic kidney disease: a two-year follow-up study.
     Transplant Proc, 43(5): 1839-46. [Abstract] [Full-text]
240. Myocardial perfusion is a useful screening test for the evaluation of cardiovascular risk in patients undergoing simultaneous pancreas kidney transplantation.
     Transplant Proc, 43(5): 1797-800. [Abstract] [Full-text]
241. Effect of splenic artery embolization for splenic artery steal syndrome in liver transplant recipients: estimation at computed tomography based on changes in caliber of related arteries.
     Transplant Proc, 43(5): 1790-3. [Abstract] [Full-text]
242. Laparoscopic incisional hernia repair after solid-organ transplantation.
     Transplant Proc, 43(5): 1783-9. [Abstract] [Full-text]
243. Safety of ultra-rapid intravenous infusion of hepatitis B immunoglobulin in liver transplant recipients.
     Transplant Proc, 43(5): 1780-2. [Abstract] [Full-text]
244. Early diagnostic value of plasma PCT and BG assay for CRBSI after OLT.
     Transplant Proc, 43(5): 1777-9. [Abstract] [Full-text]
245. Chronic hepatic artery occlusion with collateral formation: imaging findings and outcomes.
     Transplant Proc, 43(5): 1770-6. [Abstract] [Full-text]
246. Simultaneous surgical repair for combined biliary and arterial stenoses after liver transplantation.
     Transplant Proc, 43(5): 1765-9. [Abstract] [Full-text]
247. Update on biliary strictures in liver transplants.
     Transplant Proc, 43(5): 1760-4. [Abstract] [Full-text]
248. Liver retransplantation in superobese patients: a single center experience.
     Transplant Proc, 43(5): 1757-9. [Abstract] [Full-text]
249. Motivations and decision-making dilemmas of overseas liver transplantation: Taiwan recipients' perspectives.
     Transplant Proc, 43(5): 1754-6. [Abstract] [Full-text]
250. Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population.
     Transplant Proc, 43(5): 1751-3. [Abstract] [Full-text]
251. Prospective validation of a simple laboratory score to predict outcome after orthotopic liver transplantation.
     Transplant Proc, 43(5): 1747-50. [Abstract] [Full-text]
252. Rehospitalization after kidney transplantation during the first year: length, causes and relationship with long-term patient and graft survival.
     Transplant Proc, 43(5): 1742-6. [Abstract] [Full-text]
253. Split liver transplantation.
     Transplant Proc, 43(5): 1736-41. [Abstract] [Full-text]
254. New prognostic model for adult-to-adult living donor liver transplant recipients.
     Transplant Proc, 43(5): 1728-35. [Abstract] [Full-text]
255. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience.
     Transplant Proc, 43(5): 1725-7. [Abstract] [Full-text]
256. Long-term outcome of hepatic artery reconstruction during living-donor liver transplantation.
     Transplant Proc, 43(5): 1720-4. [Abstract] [Full-text]
257. Versatility of right gastroepiploic and gastroduodenal arteries for arterial reconstruction in adult living donor liver transplantation.
     Transplant Proc, 43(5): 1716-9. [Abstract] [Full-text]
258. Statistical modeling of hemodynamic changes during orthotopic liver transplantation: predictive value for outcome and effect of marginal donors.
     Transplant Proc, 43(5): 1711-5. [Abstract] [Full-text]
259. Intraoperative calcium-related risk factors for biochemical acute pancreatitis after living-donor liver transplantation.
     Transplant Proc, 43(5): 1706-10. [Abstract] [Full-text]
260. Decreased circulating CD4+CD25highFoxp3+ T cells during acute rejection in liver transplant patients.
     Transplant Proc, 43(5): 1696-700. [Abstract] [Full-text]
261. Preoperative echocardiographic indices associated with elevated brain natriuretic peptide in liver transplant recipients.
     Transplant Proc, 43(5): 1691-5. [Abstract] [Full-text]
262. Evaluation of intraoperative brain natriuretic peptide as a predictor of 1-year mortality after liver transplantation.
     Transplant Proc, 43(5): 1684-90. [Abstract] [Full-text]
263. A retrospective case-control study of intraoperative cardiac dysfunction in elderly patients (≥60 years) undergoing live donor liver transplantation.
     Transplant Proc, 43(5): 1678-83. [Abstract] [Full-text]
264. Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation.
     Transplant Proc, 43(5): 1674-7. [Abstract] [Full-text]
265. Starting hemoglobin value predicts early phase prognosis after liver transplantation.
     Transplant Proc, 43(5): 1669-73. [Abstract] [Full-text]
266. Comparison of acute physiology and chronic health evaluation II death risk, Child-Pugh, Charlson, and model for end-stage liver disease indexes to predict early mortality after liver transplantation.
     Transplant Proc, 43(5): 1660-4. [Abstract] [Full-text]
267. Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation.
     Transplant Proc, 43(5): 1654-9. [Abstract] [Full-text]
268. Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.
     Transplant Proc, 43(5): 1641-6. [Abstract] [Full-text]
269. Association between urothelial carcinoma after renal transplantation and infection by human papillomavirus types 16 and 18.
     Transplant Proc, 43(5): 1638-40. [Abstract] [Full-text]
270. Cytomegalovirus genotypes gB1 and gH1 are the most predominant genotypes among renal transplant recipients in Kuwait.
     Transplant Proc, 43(5): 1634-7. [Abstract] [Full-text]
271. A technique for kidney retransplantation after simultaneous kidney pancreas transplantation.
     Transplant Proc, 43(5): 1627-8. [Abstract] [Full-text]
272. Use of stenting in living donor kidney transplantation: does it reduce vesicoureteral complications?
     Transplant Proc, 43(5): 1623-6. [Abstract] [Full-text]
273. Urologic complications in more than 2500 kidney transplantations performed at the Saint Barnabas healthcare system.
     Transplant Proc, 43(5): 1619-22. [Abstract] [Full-text]
274. Vascular endothelial function of sirolimus maintenance regimen in renal transplant recipients.
     Transplant Proc, 43(5): 1616-8. [Abstract] [Full-text]
275. Dyslipidemia in human kidney transplant recipients receiving cyclosporine and tacrolimus is associated with different expression of CD36 on peripheral blood monocytes.
     Transplant Proc, 43(5): 1612-5. [Abstract] [Full-text]
276. Adiponectin gene polymorphisms are associated with posttransplantation diabetes mellitus in Chinese renal allograft recipients.
     Transplant Proc, 43(5): 1607-11. [Abstract] [Full-text]
277. Impact on health-related quality of life in kidney transplant recipients with late posttransplant anemia administered darbepoetin alfa: results from the STRATA study.
     Transplant Proc, 43(5): 1593-600. [Abstract] [Full-text]
278. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.
     Transplant Proc, 43(5): 1583-92. [Abstract] [Full-text]
279. Protocol biopsy of a transplanted kidney as a tool for monitoring adequacy of immunosuppressive therapy: 10 years of experience from a single transplant center.
     Transplant Proc, 43(5): 1576-82. [Abstract] [Full-text]
280. In vivo 31P MR spectroscopy of human kidney grafts using the 2D-chemical shift imaging method.
     Transplant Proc, 43(5): 1570-5. [Abstract] [Full-text]
281. Outcome of kidney transplantation following end-stage renal disease due to reflux nephropathy.
     Transplant Proc, 43(5): 1566-9. [Abstract] [Full-text]
282. Analysis of 80 dual-kidney transplantations: a multicenter experience.
     Transplant Proc, 43(5): 1559-65. [Abstract] [Full-text]
283. Operational tolerance in living-related renal transplantation: a single-center experience.
     Transplant Proc, 43(5): 1551-8. [Abstract] [Full-text]
284. Impact of human leukocyte antigen-DR mismatch status on kidney graft survival in a predominantly African-American population under the newer immunosuppressive era.
     Transplant Proc, 43(5): 1544-50. [Abstract] [Full-text]
285. Advanced donor age alone is not a risk factor for graft survival in kidney transplantation.
     Transplant Proc, 43(5): 1537-43. [Abstract] [Full-text]
286. Cardiovascular risk assessment among potential kidney transplant candidates and perioperative outcome: analysis of 75 consecutive Middle Eastern patients.
     Transplant Proc, 43(5): 1531-6. [Abstract] [Full-text]
287. Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts.
     Transplant Proc, 43(5): 1484-8. [Abstract] [Full-text]
288. Astragaloside IV protects against ischemia reperfusion in a murine model of orthotopic liver transplantation.
     Transplant Proc, 43(5): 1456-61. [Abstract] [Full-text]
289. Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats.
     Transplant Proc, 43(5): 1450-5. [Abstract] [Full-text]
290. Protective effect of N-acetylcysteine on early outcomes of deceased renal transplantation.
     Transplant Proc, 43(5): 1443-9. [Abstract] [Full-text]
291. Organ donor found to have von Hippel-Lindau disease: case report.
     Transplant Proc, 43(5): 1438-40. [Abstract] [Full-text]
292. Kidney donation after cardiac death in Korea.
     Transplant Proc, 43(5): 1434-7. [Abstract] [Full-text]
293. Knowledge and behavior among health professionals in relation to cadaveric organ donation and transplantation: a questionnaire-based analysis in Portuguese hospitals.
     Transplant Proc, 43(5): 1429-33. [Abstract] [Full-text]
294. Knowledge and attitudes toward organ/tissue donation and transplantation among health care professionals working in organ transplantation or dialysis units.
     Transplant Proc, 43(5): 1425-8. [Abstract] [Full-text]
295. Impact of the educational resource one life … many gifts on attitudes of secondary school students towards organ and tissue donation and transplantation.
     Transplant Proc, 43(5): 1418-20. [Abstract] [Full-text]
296. Transplantation with kidney paired donation to increase the donor pool: a single-center experience.
     Transplant Proc, 43(5): 1412-4. [Abstract] [Full-text]
297. Does stroke volume variation predict intraoperative blood loss in living right donor hepatectomy?
     Transplant Proc, 43(5): 1407-11. [Abstract] [Full-text]
298. Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review.
     Transplant Proc, 43(5): 1395-404. [Abstract] [Full-text]
299. New-onset diabetes after renal transplantation: diagnosis, incidence, risk factors, impact on outcomes, and novel implications.
     Transplant Proc, 43(5): 1375-94. [Abstract] [Full-text]
300. Atypical variant of galli-galli disease (grover-like eruption with lentiginous freckling) in a liver transplant patient.
     Am J Dermatopathol, 33(5): 504-7. [Abstract] [Full-text]
301. Elevated soluble cellular adhesion molecules are associated with increased mortality in a prospective cohort of renal transplant recipients.
     BMC Nephrol, 12: 23. [Abstract] [Full-text]
302. Accidental insertion of a percutaneous venovenous cannula into the persistent left superior vena cava of a patient undergoing liver transplantation.
     Can J Anaesth, 58(7): 646-9. [Abstract] [Full-text]
303. Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience.
     Can J Anaesth, 58(7): 599-605. [Abstract] [Full-text]
304. Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.
     J Pharmacol Exp Ther, 338(1): 143-53. [Abstract] [Full-text]
305. Long-term follow-up of living-donor single-lobe lung transplantation for bronchiolitis obliterans in a four-year-old male: improvement of over-sized lung allograft.
     Interact Cardiovasc Thorac Surg, 13(1): 114-6. [Abstract] [Full-text]
306. Predicting three-year kidney graft survival in recipients with systemic lupus erythematosus.
     ASAIO J, 57(4): 300-9. [Abstract] [Full-text]
307. Ethical considerations for ventricular assist device support: a 10-point model.
     ASAIO J, 57(4): 268-73. [Abstract] [Full-text]
308. Progressive coronary artery-pulmonary artery fistula after size-mismatch cardiac transplantation.
     ASAIO J, 57(4): 346-7. [Abstract] [Full-text]
309. The biomechanical performance of locking plate fixation with intramedullary fibular strut graft augmentation in the treatment of unstable fractures of the proximal humerus.
     J Bone Joint Surg Br, 93(7): 937-41. [Abstract] [Full-text]
310. Regulation of osteogenesis and survival within bone grafts to the calvaria: the effect of the dura versus the pericranium.
     Plast Reconstr Surg, 128(1): 85-94. [Abstract] [Full-text]
311. Monitoring tolerance and rejection in organ transplant recipients.
     Biomarkers, 16: S42-50. [Abstract] [Full-text]
312. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
     Lancet Oncol, 12(7): 654-62. [Abstract] [Full-text]
313. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry.
     Circulation, 123(25): 2975-84. [Abstract] [Full-text]
314. Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation.
     Hepatology, 54(1): 216-28. [Abstract] [Full-text]
315. Ultrastructural changes of the intracellular surfactant pool in a rat model of lung transplantation-related events.
     Respir Res, 12: 79. [Abstract] [Full-text]
316. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
     Acta Biochim Biophys Sin (Shanghai), 43(7): 576-81. [Abstract] [Full-text]
317. Does fresh osteochondral allograft transplantation of talar osteochondral defects improve function?
     Clin Orthop Relat Res, 469(8): 2356-66. [Abstract] [Full-text]

© 2004-2011 Organ Transplantation Research Today. All Rights Reserved.